A
ATAI Life Sciences NV D
D
ATAI
4.15000
USD
0.20
(4.93%)
قبل الجلسة
حجم التداول
66
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
880,396,260
العنوان: ATAI Life Sciences NV
القطاع: Healthcare
الصناعة: Biotechnology
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.